Chengdu Kanghua Biological Products

China
Chengdu, Sichuan, China, 610000

Company profile

Chengdu Kanghua Biological Products company profile

Kanghua Biological is a research and development, production, and operation of preventive biological products. The company's research and development, production base, SPF laboratory animal center, and high-tech bacterial and virus vaccine GMP production workshop occupy 30,000 square meters. Its existing product includes ACYW135 group Meningococcal Polysaccharide Vaccine, (trade name: Maicred) and Freeze-dried Rabies Vaccine for Human Use (Human Diploid Cells), (trade name: HDCV). It has been awarded the titles of "Postdoctoral Innovation Practice Base", "Sichuan Province Constructive Innovation Enterprise Cultivation Enterprise", "Sichuan Province Excellent Integrity Demonstration Unit" by the Personnel Department and the Science and Technology Department. It was founded in 2004 in Chengdu, Sichuan, China.

Business identity

Contact email
[email protected]
Phone number
(86) 028-84846555
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Founded
2004-01-01, Year

Headquarters

Postal code
610000
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
2
Last funding
Post IPO Secondary / $49.7M / 2024-09-06
Last equity funding
Private Equity
Investors
2
Lead investors
1
Articles
7
Exited on
2020-06-16

Founders and investors

Lead investors

Sichuan Development Securities Fund

Investors

Sichuan Development Securities FundYingke Capital